Xinxing Cathay wins Chinese antitrust clearance for Hainan Haiyao deal
MLex Summary: The proposed acquisition by Xinxing Cathay International Pharmaceutical Holdings of control of pharmaceutical products maker Hainan Haiyao has received antitrust clearance from China’s State Administration for Market Regulation, Shenzhen-listed...To view the full article, register now.
Already a subscriber? Click here to view full article